YH
Yogesh Hari Ughada
About Yogesh Hari Ughada
Data last updated:
Yogesh Hari Ughada is a Director at Lasa Supergenerics Limited (since 2025). The company operates in Pharma. Lasa Supergenerics Limited reported revenue of ₹147 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lasa Supergenerics Limited L24233MH2016PLC274202 | Director | 04 Aug 2025 | 2016 | ₹147 Cr (FY 2025) | Active |
Board colleagues of Yogesh Hari Ughada
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ganesh Suresh Potdar | 11455401 | Lasa Supergenerics Limited | Additional Director |
| Ketan Bhau Songal | 11228418 | Lasa Supergenerics Limited | Director |
| Mitti Mitesh Jain | Lasa Supergenerics Limited | Company Secretary | |
| Omkar Pravin Herlekar | 01587154 | Lasa Supergenerics Limited | Managing Director |
| Pravin Gadalya Lachake | 11228417 | Lasa Supergenerics Limited | Director |
| Rekha Hemant Wakh | 11229667 | Lasa Supergenerics Limited | Director |
| Varsha Pravin Joshi | Lasa Supergenerics Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yogesh Hari Ughada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yogesh Hari Ughada
Yogesh Hari Ughada currently holds 1 directorship: Lasa Supergenerics Limited (Director, since 04 Aug 2025, revenue ₹147 Cr (FY 2025)).
Yogesh Hari Ughada was first appointed on 04 Aug 2025 as Director at Lasa Supergenerics Limited.
The current boards of Yogesh Hari Ughada's companies include Ganesh Suresh Potdar (Lasa Supergenerics Limited), Ketan Bhau Songal (Lasa Supergenerics Limited), Mitti Mitesh Jain (Lasa Supergenerics Limited), Omkar Pravin Herlekar (Lasa Supergenerics Limited), Pravin Gadalya Lachake (Lasa Supergenerics Limited), Rekha Hemant Wakh (Lasa Supergenerics Limited), among others.